Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 4

Biologics: Targets and Therapy


Archived Journals

Archive: Volume 2, 2008


Efalizumab-induced severe thrombocytopenia can be resolved

Francesca Prignano, F Zanieri, S Mokhtarzadeh, T Lotti

Biologics: Targets and Therapy 2008, 2:923-927

Published Date: 5 December 2008

Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome

Dominic C Chow, Anne Tasaki, Jill Ono, Bruce Shiramizu, Scott A Souza

Biologics: Targets and Therapy 2008, 2:917-921

Published Date: 5 December 2008

Rituximab therapy in Greek patients with rheumatoid arthritis

Aristotelis P Tsiakalos, Nestor K Avgoustidis, Haralampos M Moutsopoulos

Biologics: Targets and Therapy 2008, 2:911-916

Published Date: 5 December 2008

Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy

Maristella D’Uva, Pierpaolo Di Micco, Ida Strina, Antonio Ranieri, Carlo Alviggi, et al

Biologics: Targets and Therapy 2008, 2:897-902

Published Date: 5 December 2008

Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines

Faten Merhi, Jacques Auger, Francine Rendu, Brigitte Bauvois

Biologics: Targets and Therapy 2008, 2:885-895

Published Date: 5 December 2008

Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels

Parmeet Kaur Manchanda, Anant Kumar, Raj K Sharma, Himanshu Goel, Rama Devi Mittal

Biologics: Targets and Therapy 2008, 2:875-884

Published Date: 5 December 2008

Abatacept in difficult-to-treat juvenile idiopathic arthritis

Jasmin B Kuemmerle-Deschner, SM Benseler

Biologics: Targets and Therapy 2008, 2:865-874

Published Date: 5 December 2008

The insulin-like growth factor system and its receptors: A potential novel anticancer target

Colin R. Lindsay, T R Jeffry Evans

Biologics: Targets and Therapy 2008, 2:855-864

Published Date: 5 December 2008

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

Fernando C Fervenza, Roser Torra, David G Warnock

Biologics: Targets and Therapy 2008, 2:823-843

Published Date: 5 December 2008

Bevacizumab in the treatment of HER2-negative breast cancer

Vito Lorusso

Biologics: Targets and Therapy 2008, 2:813-821

Published Date: 5 December 2008

Novel microtubule-targeting agents – the epothilones

Kit L Cheng, Thomas Bradley, Daniel R Budman

Biologics: Targets and Therapy 2008, 2:789-811

Published Date: 5 December 2008

Adalimumab for the treatment of Crohn’s disease

Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro

Biologics: Targets and Therapy 2008, 2:763-777

Published Date: 5 December 2008

Therapeutic vaccines for malignant brain tumors

Michael P Gustafson, Keith L Knutson, Allan B Dietz

Biologics: Targets and Therapy 2008, 2:753-761

Published Date: 5 December 2008

α-L-iduronidase therapy for mucopolysaccharidosis type I

Jakub Tolar, Paul J Orchard

Biologics: Targets and Therapy 2008, 2:743-751

Published Date: 5 December 2008

Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)

Leigh D Church, Sinisa Savic, Michael F McDermott

Biologics: Targets and Therapy 2008, 2:733-742

Published Date: 5 December 2008

The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer

Masahide Matsuyama, Rikio Yoshimura

Biologics: Targets and Therapy 2008, 2:725-732

Published Date: 5 December 2008

Denileukin diftitox for the treatment of cutaneous T-cell lymphoma

David Kaminetzky, Kenneth B Hymes

Biologics: Targets and Therapy 2008, 2:717-724

Published Date: 5 December 2008

Small molecule tyrosine kinase inhibitors in pancreatic cancer

Sachin Gupta, Bassel F El-Rayes

Biologics: Targets and Therapy 2008, 2:707-715

Published Date: 5 December 2008

Biological drugs targeting the immune response in the therapy of psoriasis

Saveria Pastore, Emanuela Gubinelli, Luca Leoni, Desanka Raskovic, Liudmila Korkina

Biologics: Targets and Therapy 2008, 2:687-697

Published Date: 5 December 2008

Anticomplement therapy

Prathit A Kulkarni, Vahid Afshar-Kharghan

Biologics: Targets and Therapy 2008, 2:671-685

Published Date: 5 December 2008

Denosumab: an investigational drug for the management of postmenopausal osteoporosis

E Michael Lewiecki

Biologics: Targets and Therapy 2008, 2:645-653

Published Date: 5 December 2008

Rituximab in the treatment of non-Hodgkin’s lymphoma

Beate Hauptrock, Georg Hess

Biologics: Targets and Therapy 2008, 2:619-633

Published Date: 5 December 2008

Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma

Camillo Porta, Chiara Paglino, Luciano Mutti

Biologics: Targets and Therapy 2008, 2:601-609

Published Date: 5 December 2008

Clinical use of topical thrombin as a surgical hemostat

Wesley K Lew, Fred A Weaver

Biologics: Targets and Therapy 2008, 2:593-599

Published Date: 5 December 2008